Last quarter (Q4 2023), Vertex Pharmaceuticals's total revenue was $2.52B, an increase of 9.34% from the same quarter last year. In Q4, Vertex Pharmaceuticals's net income was $968.80M. See Vertex Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 9.87B	$ 9.87B	$ 8.93B	$ 7.57B	$ 6.21B	$ 4.16B
Cost of Revenue	$ 1.26B	$ 1.26B	$ 1.08B	$ 904.20M	$ 736.30M	$ 547.76M
Gross Profit	$ 8.61B	$ 8.61B	$ 7.85B	$ 6.67B	$ 5.47B	$ 3.62B
Operating Expense	$ 4.83B	$ 4.83B	$ 3.60B	$ 3.89B	$ 2.60B	$ 2.41B
Operating Income	$ 3.83B	$ 3.83B	$ 4.25B	$ 2.78B	$ 2.87B	$ 1.20B
Net Non Operating Interest Income Expense	$ -44.10M	$ -44.10M	-	$ 47.40M	$ -36.00M	$ 5.18M
Other Income Expense	$ -643.50M	$ -643.50M	$ -37.30M	$ -12.90M	$ 283.50M	$ 187.72M
Pretax Income	$ 4.38B	$ 4.38B	$ 4.23B	$ 2.73B	$ 3.12B	$ 1.39B
Tax Provision	$ 760.20M	$ 760.20M	$ 910.40M	$ 388.30M	$ 405.20M	$ 218.11M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 3.62B	$ 3.62B	$ 3.32B	$ 2.34B	$ 2.71B	$ 1.18B
Basic EPS	$ 14.04	$ 14.05	$ 12.97	$ 9.09	$ 10.44	$ 4.58
Diluted EPS	$ 13.90	$ 13.89	$ 12.82	$ 9.01	$ 10.29	$ 4.51
Basic Average Shares	$ 1.03B	$ 257.70M	$ 256.10M	$ 257.70M	$ 259.84M	$ 256.73M
Diluted Average Shares	$ 1.04B	$ 260.50M	$ 259.10M	$ 259.90M	$ 263.40M	$ 260.67M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ 10.32	$ 5.33
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 6.09B	$ 6.09B	$ 4.68B	$ 4.80B	$ 3.34B	$ 2.96B
Net Income From Continuing And Discontinued Operation	$ 3.62B	$ 3.62B	$ 3.32B	$ 2.34B	$ 2.71B	$ 1.18B
Normalized Income	$ 2.72B	$ 3.42B	-	-	$ 2.72B	$ 1.18B
Interest Expense	-	-	-	-	$ 58.20M	$ 58.50M
EBIT	$ 4.44B	$ 4.42B	$ 4.23B	$ 2.79B	$ 3.18B	$ 1.45B
EBITDA	$ 3.38B	$ 4.61B	$ 4.38B	$ 2.92B	$ 3.28B	$ 1.56B

Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing